KalVista Pharmaceuticals, Inc.
KALVDelisted Jun 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348911
KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.
13F holders, Q1 2026
Institutional positions in KalVista Pharmaceuticals, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
KALV is no longer listed, so this page shows Q1 2026. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 184
- +25 vs. Q4 2025
- Shares held
- 69.3M
- +4.82M (+7.5%) vs. Q4 2025
- Total value
- $1.39B
- +$353.2M (+33.9%) vs. Q4 2025
- New holders
- 41
- 64 more added
- Sold out
- 16
- 45 more reduced
3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KALV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $189 |
| Q1 2026 | 184 | $1.39B |
| Q4 2025 | 162 | $1.08B |
| Q3 2025 | 145 | $714.0M |
| Q2 2025 | 140 | $615.5M |
| Q1 2025 | 128 | $633.7M |
| Q4 2024 | 130 | $467.4M |
| Q3 2024 | 122 | $561.0M |
| Q2 2024 | 119 | $568.2M |
| Q1 2024 | 129 | $557.2M |
| Q4 2023 | 93 | $453.0M |
| Q3 2023 | 101 | $349.2M |
| Q2 2023 | 94 | $310.1M |
| Q1 2023 | 88 | $265.0M |
| Q4 2022 | 91 | $236.2M |
| Q3 2022 | 94 | $372.0M |
| Q2 2022 | 91 | $238.7M |
| Q1 2022 | 89 | $363.9M |
| Q4 2021 | 97 | $314.6M |
| Q3 2021 | 105 | $408.2M |
| Q2 2021 | 110 | $582.7M |
| Q1 2021 | 117 | $605.1M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding KalVista Pharmaceuticals, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Man Group plc | 42,576 | $857.1K | 0.00% | +25,130+144.0% | Added |
| Lisanti Capital Growth, LLC | 43,775 | $881.2K | 0.22% | +43,775 | New |
| Susquehanna International Group, LLP | 46,760 | $941.3K | 0.00% | −25,135−35.0% | Reduced |
| Rhumbline Advisers | 47,469 | $955.5K | 0.00% | +78+0.2% | Added |
| Virtus Investment Advisers, Inc. | 49,927 | $1.01M | 0.28% | +9,513+23.5% | Added |
| Panagora Asset Management Inc | 50,792 | $1.02M | 0.00% | −58,599−53.6% | Reduced |
| CenterBook Partners LP | 53,264 | $1.07M | 0.06% | +53,264 | New |
| Swiss National Bank | 54,900 | $1.11M | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 56,192 | $1.13M | 0.00% | −57−0.1% | Reduced |
| Birchview Capital, LP | 57,000 | $1.15M | 0.65% | 00.0% | Unchanged |
| Rafferty Asset Management, LLC | 57,296 | $1.15M | 0.00% | −8,297−12.6% | Reduced |
| Creative Planning | 59,986 | $1.21M | 0.00% | +15,904+36.1% | Added |
| Campbell & CO Investment Adviser LLC | 64,249 | $1.29M | 0.07% | +64,249 | New |
| Swiss Life Asset Management Ltd | 21,885 | $1.38M | 0.01% | +21,885 | New |
| Martingale Asset Management L P | 69,945 | $1.41M | 0.04% | +39,006+126.1% | Added |
| Invesco Ltd. | 75,282 | $1.52M | 0.00% | −2,582−3.3% | Reduced |
| XTX Topco Ltd | 79,118 | $1.59M | 0.03% | +52,610+198.5% | Added |
| Walleye Capital LLC | 79,666 | $1.60M | 0.01% | +79,666 | New |
| OrbiMed Advisors LLC | 94,400 | $1.90M | 0.04% | −288,000−75.3% | Reduced |
| Citadel Advisors LLC | 97,726 | $1.97M | 0.00% | +59,965+158.8% | Added |
| Nuveen, LLC | 106,864 | $2.15M | 0.00% | −265−0.2% | Reduced |
| Wellington Management Group LLP | 107,262 | $2.16M | 0.00% | −15,117−12.4% | Reduced |
| Brevan Howard Capital Management LP | 125,049 | $2.42M | 0.02% | +65,902+111.4% | Added |
| Seven Fleet Capital Management LP | 128,487 | $2.59M | 0.81% | +80,075+165.4% | Added |
| NEXTBio Capital Management LP | 131,796 | $2.65M | 1.23% | 00.0% | Unchanged |
| Trexquant Investment LP | 139,458 | $2.81M | 0.02% | +139,458 | New |
| Raymond James Financial Inc | 140,651 | $2.83M | 0.00% | +11,134+8.6% | Added |
| Squarepoint Ops LLC | 143,966 | $2.90M | 0.01% | +143,966 | New |
| Two Sigma Investments, LP | 153,459 | $3.09M | 0.00% | +153,459 | New |
| Nan Fung Trinity (HK) Ltd | 154,522 | $3.11M | 0.34% | 00.0% | Unchanged |
| Marshall Wace, LLP | 162,908 | $3.28M | 0.00% | +162,908 | New |
| ExodusPoint Capital Management, LP | 177,274 | $3.57M | 0.04% | +157,213+783.7% | Added |
| Qube Research & Technologies Ltd | 180,314 | $3.63M | 0.01% | +180,314 | New |
| FMR LLC | 187,848 | $3.78M | 0.00% | +76,041+68.0% | Added |
| Blue Owl Capital Holdings LP | 215,000 | $4.33M | 1.16% | −145,000−40.3% | Reduced |
| F/M Investments LLC | 226,991 | $4.57M | 0.30% | −9,699−4.1% | Reduced |
| Ameriprise Financial Inc | 229,984 | $4.63M | 0.00% | +195,055+558.4% | Added |
| Citigroup Inc | 244,261 | $4.92M | 0.00% | +233,490+2,167.8% | Added |
| Atom Investors LP | 245,993 | $4.95M | 0.35% | −30,120−10.9% | Reduced |
| DAFNA Capital Management LLC | 267,402 | $5.38M | 1.22% | −89,400−25.1% | Reduced |
| Vanguard Fiduciary Trust Co | 276,391 | $5.56M | 0.00% | +276,391 | New |
| Ishara Investments LP | 276,750 | $5.57M | 5.63% | +276,750 | New |
| Jefferies Financial Group Inc. | 286,046 | $5.76M | 0.07% | +286,046 | New |
| HRT Financial LP | 286,916 | $5.78M | 0.01% | −1360.0% | Reduced |
| Schonfeld Strategic Advisors LLC | 315,537 | $6.35M | 0.05% | +9,657+3.2% | Added |
| Charles Schwab Investment Management Inc | 323,451 | $6.51M | 0.00% | −918−0.3% | Reduced |
| SEB Asset Management AB | 351,305 | $7.07M | 0.03% | +351,305 | New |
| Vanguard Portfolio Management LLC | 362,900 | $7.31M | 0.00% | +362,900 | New |
| Northern Trust Corp | 363,694 | $7.32M | 0.00% | +11,721+3.3% | Added |
| Hennion & Walsh Asset Management, Inc. | 375,995 | $7.57M | 0.25% | +34,176+10.0% | Added |
| Catalio Capital Management, LP | 426,551 | $8.59M | 1.79% | +426,551 | New |
| Morgan Stanley | 439,099 | $8.84M | 0.00% | −261,129−37.3% | Reduced |
| Schroder Investment Management Group | 506,743 | $9.30M | 0.01% | −665,012−56.8% | Reduced |
| UBS Group AG | 515,650 | $10.4M | 0.00% | +143,657+38.6% | Added |
| Barclays PLC | 537,061 | $10.8M | 0.00% | −163,512−23.3% | Reduced |
| Bank of America Corp | 555,628 | $11.2M | 0.00% | +165,815+42.5% | Added |
| Driehaus Capital Management LLC | 564,039 | $11.4M | 0.08% | +564,039 | New |
| Bank of New York Mellon Corp | 584,347 | $11.8M | 0.00% | −110,828−15.9% | Reduced |
| Great Point Partners LLC | 675,000 | $13.6M | 3.33% | −10,632−1.6% | Reduced |
| Emerald Mutual Fund Advisers Trust | 805,762 | $16.2M | 0.79% | −49,699−5.8% | Reduced |
| Goldman Sachs Group Inc | 824,293 | $16.6M | 0.00% | −11,011−1.3% | Reduced |
| Freestone Grove Partners LP | 882,906 | $17.8M | 0.13% | +249,887+39.5% | Added |
| Spruce Street Capital LP | 897,681 | $18.1M | 4.34% | +509,713+131.4% | Added |
| Squadron Capital Management LLC | 985,100 | $19.8M | 7.93% | +285,100+40.7% | Added |
| Geode Capital Management, LLC | 996,235 | $20.1M | 0.00% | +52,158+5.5% | Added |
| Elmind Capital, LP | 1,021,300 | $20.6M | 5.84% | +220,000+27.5% | Added |
| Armistice Capital, LLC | 1,236,000 | $24.9M | 0.82% | +436,000+54.5% | Added |
| Emerald Advisers, LLC | 1,264,023 | $25.4M | 0.81% | −76,472−5.7% | Reduced |
| Octagon Capital Advisors LP | 1,450,000 | $29.2M | 3.23% | +176,667+13.9% | Added |
| Woodline Partners LP | 1,509,920 | $30.4M | 0.11% | −411,172−21.4% | Reduced |
| Kynam Capital Management, LP | 1,820,954 | $36.7M | 2.33% | +10,000+0.6% | Added |
| Vanguard Capital Management LLC | 1,830,467 | $36.8M | 0.00% | +1,830,467 | New |
| Parkman Healthcare Partners LLC | 1,835,506 | $36.9M | 3.83% | +66,998+3.8% | Added |
| Vestal Point Capital, LP | 1,850,000 | $37.2M | 1.04% | −40,000−2.1% | Reduced |
| Millennium Management LLC | 1,912,146 | $38.5M | 0.03% | −984,520−34.0% | Reduced |
| State Street Corp | 1,955,844 | $39.4M | 0.00% | +44,153+2.3% | Added |
| Point72 Asset Management, L.P. | 2,136,940 | $43.0M | 0.07% | −146,826−6.4% | Reduced |
| Capital World Investors | 2,808,583 | $56.5M | 0.01% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 2,876,407 | $57.9M | 6.82% | +449,289+18.5% | Added |
| BlackRock, Inc. | 3,795,897 | $76.4M | 0.00% | +41,749+1.1% | Added |
| Tang Capital Management LLC | 4,573,530 | $92.1M | 4.68% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 4,768,712 | $96.0M | 2.60% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 4,961,108 | $99.9M | 2.57% | −78,759−1.6% | Reduced |
| VR Adviser, LLC | 6,474,485 | $130.3M | 4.86% | −254,500−3.8% | Reduced |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −351,305−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −165,151−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −117,907−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −90,742−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −52,190−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −31,608−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −23,370−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −13,110−100.0% | Sold out |
| Intech Investment Management LLC | 0 | $0 | 0.00% | −12,919−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −10,938−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −3,777−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,205−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −278−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Garner Asset Management Corp | 0 | $0 | 0.00% | −135−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −154−100.0% | Sold out |